Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$26.39 USD
0.00 (0.00%)
Updated May 30, 2024 04:00 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Revenue - Line of Business Segments | YR Estimate | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|---|
Revenue: Royalty Receipts: Growth... |
-- | 116 | 97 | 36 | -- | -- |
Revenue: Royalty Receipts: Growth... |
-- | 18 | 15 | 70 | 4 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 66 | 55 | 34 | -- | -- |
Revenue: Royalty Receipts: Growth... |
-- | 66 | 41 | 16 | 0 | -- |
Revenue: Royalty Receipts: Growth... |
-- | -- | 37 | 38 | 21 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 33 | 20 | 13 | 3 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 29 | 22 | 7 | -- | -- |
Revenue: Royalty Receipts: Growth... |
-- | -- | 3 | 1 | -- | -- |
Revenue: Total Royalty Receipts: ... |
-- | 2,449 | 2,269 | 2,609 | 2,344 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 203 | 90 | -- | -- | -- |
Revenue: Royalty Receipts: Growth... |
-- | 771 | 690 | 702 | 551 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 279 | 305 | 369 | 346 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 210 | 258 | 353 | 322 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 161 | 150 | 174 | 144 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 146 | 154 | 158 | 146 | -- |
Revenue: Royalty Receipts: Growth... |
-- | -- | 44 | 36 | 25 | -- |
Revenue: Royalty Receipts: Growth... |
-- | -- | 20 | 17 | 9 | -- |
Revenue: Royalty Receipts: Growth... |
-- | -- | 19 | 15 | 10 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 27 | 18 | 14 | 8 | -- |
Revenue: Royalty Receipts: Growth... |
-- | 277 | 355 | 404 | 311 | -- |